Nicole Godresse
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Nicole Godresse
Global Chief Sales Officer / MGC Pharmaceuticals
Nicole Godresse has over 20 years of experience in the pharmaceutical and healthcare industry, holding senior commercial roles with major multinational companies including Eli Lilly, Johnson & Johnson, Schering-Plough, Merck Sharp & Dohme, and Tilray.
Ms Godresse is a true pioneer of medicinal cannabis in Australia, New Zealand and the broader Asia Pacific region. In her most recent roles as general manager of ANZ and director of emerging markets at Tilray, Ms Godresse was Instrumental in launching the first Medical Cannabis brand legally in Australia and New Zealand, launching one of the first Medical Cannabis clinics in Australia, delivering some of Australia's first government-funded cannabis clinical trials, negotiating major exclusive government supply agreements, and establishing a sustained market leadership position in both markets during her tenure. She also made significant inroads into Asia including negotiating the supply of CBD product imports into the region.
Ms Godresse is a true pioneer of medicinal cannabis in Australia, New Zealand and the broader Asia Pacific region. In her most recent roles as general manager of ANZ and director of emerging markets at Tilray, Ms Godresse was Instrumental in launching the first Medical Cannabis brand legally in Australia and New Zealand, launching one of the first Medical Cannabis clinics in Australia, delivering some of Australia's first government-funded cannabis clinical trials, negotiating major exclusive government supply agreements, and establishing a sustained market leadership position in both markets during her tenure. She also made significant inroads into Asia including negotiating the supply of CBD product imports into the region.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 91st | Botanix Pharmaceuticals | 100% | 43% |
| 335th | MGC Pharmaceuticals | 26% | -22% |
| 840th | HITIQ | -7% | |
| 1094th | rent.com.au | -25% | -13% |
| 1095th | Adisyn | -25% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 125th |  | MGC Pharmaceuticals | $4.2m |
| 132nd | | Botanix Pharmaceuticals | $3.8m |
| 135th |  | HITIQ | $3.2m |
| 137th |  | Adisyn | $2.9m |
| 138th | | rent.com.au | $2.8m |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Global Chief Sales Officer, MGC Pharmaceuticals | 16 Jan 2021 |
